AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Using points for low value items can waste your rewards. Discover smarter choices to make the most of your credit card benefits.
24,708 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Clive Davis, the legendary talent scout who built Arista and launched icons like Whitney Houston, has died at age 94,...
As AI demand climbs, power reliability becomes the bottleneck. This energy stock helping power AI offers a way to inv...
Retirees face a stubborn reality: utility bills keep arriving. A disciplined mix of dividend growth stocks, inflation...
A mid-year luxury market report shows AI-generated fortunes fueling a luxury buyers shift wealth, driving demand for ...
A chance meetup during a demanding climb sparked a generous gift and a broader lesson in smart giving. This article d...
SpaceX has captured headlines with a blockbuster IPO, but the stock has cooled. This article breaks down how historic...
Vitalik Buterin unveiled a three- to four-year Lean Ethereum upgrade, placing ETH’s institutional appeal on a four-ye...
YieldMax’s Ultra Option Income Strategy ETF (ULTY) keeps paying weekly, but volatility is the fuel and risk. This rep...
Fiserv announced the resignation of fiserv president dhivya suryadevara after less than a month in the role, with int...
Retirees weighing a $600,000 nest egg are weighing Panama and Portugal for how far the money goes, considering living...
A senior executive at Invesco disclosed a stock sale as the shares jumped about 63%. This article digs into what this...